Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!About IPHA
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOJonathan Dickinson
CEOJonathan Dickinson
Employees181
Employees181
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees181
Employees181
IPHA Key Statistics
Market cap160.66M
Market cap160.66M
Price-Earnings ratio-2.64
Price-Earnings ratio-2.64
Dividend yield—
Dividend yield—
Average volume6.79K
Average volume6.79K
High today$1.81
High today$1.81
Low today$1.70
Low today$1.70
Open price$1.75
Open price$1.75
Volume4.89K
Volume4.89K
52 Week high$3.51
52 Week high$3.51
52 Week low$1.29
52 Week low$1.29